PURPOSE: To evaluate the evolution of unidentified bright objects (UBOs) in individuals with neurofibromatosis type 1 (NF1) by serial magnetic resonance imaging (MRI), and to relate this to regional fractional anisotropy (FA). MATERIALS AND METHODS: The signal pattern of the T2-weighted sequences in the basal ganglia, thalamus, brain stem, and cerebellum for 27 NF1 individuals and a control group were analyzed by diffusion tensor imaging (DTI). The presence or absence of UBOs in 2 consecutive MRI examinations was related to FA. RESULTS: We demonstrated significant differences in FA for the basal ganglia, cerebellum, and thalamus between NF1 patients and controls (P ≤ 0.05), even with a reduction or disappearance of UBOs. CONCLUSIONS: MRI allows for adequate monitoring of the temporal and spatial distribution of UBOs in patients with NF1. DTI confirmed changes in FA despite the disappearance or reduction of UBOs, thereby confirming the hypothesis that microstructural damage occurs in specific brain regions of NF1 patients.
PURPOSE: To evaluate the evolution of unidentified bright objects (UBOs) in individuals with neurofibromatosis type 1 (NF1) by serial magnetic resonance imaging (MRI), and to relate this to regional fractional anisotropy (FA). MATERIALS AND METHODS: The signal pattern of the T2-weighted sequences in the basal ganglia, thalamus, brain stem, and cerebellum for 27 NF1 individuals and a control group were analyzed by diffusion tensor imaging (DTI). The presence or absence of UBOs in 2 consecutive MRI examinations was related to FA. RESULTS: We demonstrated significant differences in FA for the basal ganglia, cerebellum, and thalamus between NF1patients and controls (P ≤ 0.05), even with a reduction or disappearance of UBOs. CONCLUSIONS: MRI allows for adequate monitoring of the temporal and spatial distribution of UBOs in patients with NF1. DTI confirmed changes in FA despite the disappearance or reduction of UBOs, thereby confirming the hypothesis that microstructural damage occurs in specific brain regions of NF1patients.
Authors: Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman Journal: Neuroradiol J Date: 2014-09-25
Authors: Marisa Loitfelder; Stephan C J Huijbregts; Ilya Milos Veer; Hanna S Swaab; Mark A Van Buchem; Reinhold Schmidt; Serge A Rombouts Journal: Brain Connect Date: 2015-03-31
Authors: Francesco Nicita; Claudio Di Biasi; Saadi Sollaku; Stefano Cecchini; Vincenzo Salpietro; Angelo Pittalis; Laura Papetti; Fabiana Ursitti; Fiorenza Ulgiati; Anna Maria Zicari; Gian Franco Gualdi; Enrico Properzi; Marzia Duse; Martino Ruggieri; Alberto Spalice Journal: Childs Nerv Syst Date: 2013-07-27 Impact factor: 1.475
Authors: S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros Journal: AJNR Am J Neuroradiol Date: 2020-08-13 Impact factor: 3.825
Authors: Katherine A White; Vicki J Swier; Jacob T Cain; Jordan L Kohlmeyer; David K Meyerholz; Munir R Tanas; Johanna Uthoff; Emily Hammond; Hua Li; Frank A Rohret; Adam Goeken; Chun-Hung Chan; Mariah R Leidinger; Shaikamjad Umesalma; Margaret R Wallace; Rebecca D Dodd; Karin Panzer; Amy H Tang; Benjamin W Darbro; Aubin Moutal; Song Cai; Wennan Li; Shreya S Bellampalli; Rajesh Khanna; Christopher S Rogers; Jessica C Sieren; Dawn E Quelle; Jill M Weimer Journal: JCI Insight Date: 2018-06-21
Authors: Thibo Billiet; Burkhard Mädler; Felice D'Arco; Ronald Peeters; Sabine Deprez; Ellen Plasschaert; Alexander Leemans; Hui Zhang; Bea Van den Bergh; Mathieu Vandenbulcke; Eric Legius; Stefan Sunaert; Louise Emsell Journal: Neuroimage Clin Date: 2014-04-13 Impact factor: 4.881